Missouri Code of State Regulations
Title 19 - DEPARTMENT OF HEALTH AND SENIOR SERVICES
Division 30 - Division of Regulation and Licensure
Chapter 40 - Comprehensive Emergency Medical Services Systems Regulations
Section 19 CSR 30-40.780 - Definitions and Abbreviations Relating to the Transport Protocol for Stroke and the Transport Protocol for ST-Segment Elevation Myocardial Infarction (STEMI) Patients
Universal Citation: 19 MO Code of State Regs 30-40.780
Current through Register Vol. 49, No. 18, September 16, 2024
PURPOSE: This rule defines terminology related to the state transport protocol for stroke and the state transport protocol for STEMI.
(1) The following definitions and abbreviations shall be used in the interpretation of the rule in 19 CSR 30-40.790:
(A)
Field is the specific area or location, outside of the hospital, where an
injury, accident, or medical emergency occurs requiring immediate assistance of
medical personnel for the purpose of treating or transporting the sick or
injured to another location for treatment;
(B) Local and regional process is the process
that has been established and agreed upon specifically pertaining to a local
city, town, or small district, or a combination of localities forming a
regional area. This is not the community-based or regional plan;
(C) Lytics are thrombolytic drugs, including
recombinant tissue plasminogen activator, used to dissolve clots blocking flow
in a blood vessel. These lytic/thrombolytic drugs are used in the treatment of
acute ischemic stroke and acute myocardial infarction;
(D) Lytic/therapeutic window is the period of
time during which lytics can be administered following the onset of symptoms in
order to reduce brain or heart injury;
(E) Lytic therapy
(fibrinolysis/thromboly-sis) is drug therapy used to dissolve clots blocking
flow in a blood vessel. It refers to drugs used for that purpose, including
recombinant tissue plasminogen activator. This type of therapy can be used in
the treatment of acute ischemic stroke and acute myocardial
infarction;
(F) Lytic/thrombolytic
ineligible patients are those patients identified as ineligible for
lytic/thrombolytic therapy due to specific contraindications. An appropriate
course of treatment will be utilized when lytic/thrombolytic therapy is
contraindicated;
(G) Out of the
lytic/therapeutic or potential therapeutic window is the period of time
following the accepted time (lytic/therapeutic window and potential therapeutic
window) frames for specific therapies for a patient suffering an ischemic
stroke;
(H) Outside of the
percutaneous coronary intervention (PCI) window is the period of time following
the accepted time frame in which PCI is most advantageous and
recommended;
(I) Percutaneous
coronary intervention (PCI) is a procedure used to open or widen narrowed or
blocked blood vessels to restore blood flow supplying the heart;
(J) Percutaneous coronary intervention (PCI)
window is a time frame in which PCI is most advantageous and
recommended;
(K) Potential
therapeutic window is the period of time after the accepted window for lytic
therapy has expired in which interventional therapy may be beneficial in
restoring blood flow during an ischemic stroke; and
(L) Recombinant tissue plasminogen activator
(t-PA also known as rt-PA) is a thrombolytic (clot-dissolving) agent, the goal
of which is to destroy the thrombus (clot) within the blood vessel by
stimulating fibrinolysis (clot breakdown) to allow restoration of blood
flow.
*Original authority: 190.185, RSMo 1973, amended 1989, 1993, 1995, 1998, 2002 and 190.241, RSMo 1987, amended 1998, 2008.
Disclaimer: These regulations may not be the most recent version. Missouri may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
